Zika Virus—A Reemerging Neurotropic Arbovirus Associated with Adverse Pregnancy Outcomes and Neuropathogenesis

Zika virus (ZIKV) is a reemerging flavivirus that is primarily spread through bites from infected mosquitos. It was first discovered in 1947 in sentinel monkeys in Uganda and has since been the cause of several outbreaks, primarily in tropical and subtropical areas. Unlike earlier outbreaks, the 201...

Full description

Bibliographic Details
Main Authors: Kenneth C. Elliott, Joseph J. Mattapallil
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/13/2/177
_version_ 1797297283885170688
author Kenneth C. Elliott
Joseph J. Mattapallil
author_facet Kenneth C. Elliott
Joseph J. Mattapallil
author_sort Kenneth C. Elliott
collection DOAJ
description Zika virus (ZIKV) is a reemerging flavivirus that is primarily spread through bites from infected mosquitos. It was first discovered in 1947 in sentinel monkeys in Uganda and has since been the cause of several outbreaks, primarily in tropical and subtropical areas. Unlike earlier outbreaks, the 2015–2016 epidemic in Brazil was characterized by the emergence of neurovirulent strains of ZIKV strains that could be sexually and perinatally transmitted, leading to the Congenital Zika Syndrome (CZS) in newborns, and Guillain-Barre Syndrome (GBS) along with encephalitis and meningitis in adults. The immune response elicited by ZIKV infection is highly effective and characterized by the induction of both ZIKV-specific neutralizing antibodies and robust effector CD8<sup>+</sup> T cell responses. However, the structural similarities between ZIKV and Dengue virus (DENV) lead to the induction of cross-reactive immune responses that could potentially enhance subsequent DENV infection, which imposes a constraint on the development of a highly efficacious ZIKV vaccine. The isolation and characterization of antibodies capable of cross-neutralizing both ZIKV and DENV along with cross-reactive CD8<sup>+</sup> T cell responses suggest that vaccine immunogens can be designed to overcome these constraints. Here we review the structural characteristics of ZIKV along with the evidence of neuropathogenesis associated with ZIKV infection and the complex nature of the immune response that is elicited by ZIKV infection.
first_indexed 2024-03-07T22:18:07Z
format Article
id doaj.art-a04ad24895914219926077505bce8f98
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-03-07T22:18:07Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-a04ad24895914219926077505bce8f982024-02-23T15:30:26ZengMDPI AGPathogens2076-08172024-02-0113217710.3390/pathogens13020177Zika Virus—A Reemerging Neurotropic Arbovirus Associated with Adverse Pregnancy Outcomes and NeuropathogenesisKenneth C. Elliott0Joseph J. Mattapallil1Department of Microbiology & Immunology, The Henry M Jackson Foundation for Military Medicine, Uniformed Services University, Bethesda, MD 20814, USADepartment of Microbiology & Immunology, Uniformed Services University, Bethesda, MD 20814, USAZika virus (ZIKV) is a reemerging flavivirus that is primarily spread through bites from infected mosquitos. It was first discovered in 1947 in sentinel monkeys in Uganda and has since been the cause of several outbreaks, primarily in tropical and subtropical areas. Unlike earlier outbreaks, the 2015–2016 epidemic in Brazil was characterized by the emergence of neurovirulent strains of ZIKV strains that could be sexually and perinatally transmitted, leading to the Congenital Zika Syndrome (CZS) in newborns, and Guillain-Barre Syndrome (GBS) along with encephalitis and meningitis in adults. The immune response elicited by ZIKV infection is highly effective and characterized by the induction of both ZIKV-specific neutralizing antibodies and robust effector CD8<sup>+</sup> T cell responses. However, the structural similarities between ZIKV and Dengue virus (DENV) lead to the induction of cross-reactive immune responses that could potentially enhance subsequent DENV infection, which imposes a constraint on the development of a highly efficacious ZIKV vaccine. The isolation and characterization of antibodies capable of cross-neutralizing both ZIKV and DENV along with cross-reactive CD8<sup>+</sup> T cell responses suggest that vaccine immunogens can be designed to overcome these constraints. Here we review the structural characteristics of ZIKV along with the evidence of neuropathogenesis associated with ZIKV infection and the complex nature of the immune response that is elicited by ZIKV infection.https://www.mdpi.com/2076-0817/13/2/177ZikaDenguepregnancyneuropathologyCZSADE
spellingShingle Kenneth C. Elliott
Joseph J. Mattapallil
Zika Virus—A Reemerging Neurotropic Arbovirus Associated with Adverse Pregnancy Outcomes and Neuropathogenesis
Pathogens
Zika
Dengue
pregnancy
neuropathology
CZS
ADE
title Zika Virus—A Reemerging Neurotropic Arbovirus Associated with Adverse Pregnancy Outcomes and Neuropathogenesis
title_full Zika Virus—A Reemerging Neurotropic Arbovirus Associated with Adverse Pregnancy Outcomes and Neuropathogenesis
title_fullStr Zika Virus—A Reemerging Neurotropic Arbovirus Associated with Adverse Pregnancy Outcomes and Neuropathogenesis
title_full_unstemmed Zika Virus—A Reemerging Neurotropic Arbovirus Associated with Adverse Pregnancy Outcomes and Neuropathogenesis
title_short Zika Virus—A Reemerging Neurotropic Arbovirus Associated with Adverse Pregnancy Outcomes and Neuropathogenesis
title_sort zika virus a reemerging neurotropic arbovirus associated with adverse pregnancy outcomes and neuropathogenesis
topic Zika
Dengue
pregnancy
neuropathology
CZS
ADE
url https://www.mdpi.com/2076-0817/13/2/177
work_keys_str_mv AT kennethcelliott zikavirusareemergingneurotropicarbovirusassociatedwithadversepregnancyoutcomesandneuropathogenesis
AT josephjmattapallil zikavirusareemergingneurotropicarbovirusassociatedwithadversepregnancyoutcomesandneuropathogenesis